<p>Development of Anti-<em>Yersinia pestis</em> Human Antibodies with Features Required for Diagnostic and Therapeutic Applications</p>-Reference-Cited by-同舟云学术

Development of Anti-Yersinia pestis Human Antibodies with Features Required for Diagnostic and Therapeutic Applications

Published:2020-11 Issue: Volume:Volume 9 Page:299-316
ISSN:2253-1556
Container-title:ImmunoTargets and Therapy
language:en
Short-container-title:ITT

Author:

Lillo Antonietta M^ORCID,Velappan Nileena^ORCID,Kelliher Julia M^ORCID,Watts Austin J^ORCID,Merriman Samuel P,Vuyisich Grace,Lilley Laura M,Coombs Kent E^ORCID,Mastren Tara,Teshima Munehiro^ORCID,Stein Benjamin W^ORCID,Wagner Gregory L,Iyer Srinivas,Bradbury Andrew RM^ORCID,Harris Jennifer Foster^ORCID,Dichosa Armand E^ORCID,Kozimor Stosh A

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Reference78 articles.

1. Riedel S. Biological warfare and bioterrorism: a historical review. Paper presented at: Baylor University Medical Center Proceedings; 2004.

2. Lessons Learned about Pneumonic Plague Diagnosis from 2 Outbreaks, Democratic Republic of the Congo

3. The Yersinia pestis caf1M1A1 Fimbrial Capsule Operon Promotes Transmission by Flea Bite in a Mouse Model of Bubonic Plague

4. Yersinia pestis caf1 Variants and the Limits of Plague Vaccine Protection

5. Role of Fraction 1 Antigen of Yersinia pestis in Inhibition of Phagocytosis

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of human antibodies from vaccinated volunteers for protection against Yersinia pestis infection;Microbiology Spectrum;2024-08-27

2. Characterization of two affinity matured Anti-Yersinia pestis F1 human antibodies with medical countermeasure potential;PLOS ONE;2024-07-02

3. Development of ²²⁵Ac Production from Low Isotopic Dilution ²²⁹Th;ACS Omega;2023-09-27

4. Direct selection of functional fluorescent-protein antibody fusions by yeast display;PLOS ONE;2023-02-24

5. Healthy humans can be a source of antibodies countering COVID-19;Bioengineered;2022-05-02